Clinical Trial Update: Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating niclosamide as add-on therapy to standard care for COVID-19 management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars Pneumonia

Drugs mentioned

• Niclosamide (niclosamide)

Snippet

Sponsor: University of Baghdad | Conditions: Covid-19, SARS Pneumonia | Phase 2 | Status: UNKNOWN